China Continuous Glucose Monitoring Devices Market, by Component (Transmitters, Receivers, Insulin Pumps, and Sensors), and by End User (Hospitals & Clinics, Homecare Settings, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Continuous glucose monitoring (CGM) devices provide insights about glucose levels of diabetic patients throughout the day. CGM devices are mostly used by patients with type 1 and type 2 diabetes for better glucose control to improve the health and quality of life. Moreover, the integration of smartphone for easy diabetes management and cloud-based data storage are key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices display a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status.
The major factors driving growth of the continuous glucose monitoring devices market include rapid technological advancement in CGM devices along with increasing adoption of inorganic growth strategies such as collaborations and agreements to develop novel CGM devices in the market is expected to drive the market growth over the forecast period. For instance, in September 2019, Medtronic Plc. collaborated with Novo Nordisk to provide integrated digital solutions for people with diabetes. Medtronic and Novo Nordisk are collaboratively developing solutions to integrate insulin dosing data from Novo Nordisk’s smart insulin pens with Medtronic’s continuous glucose monitoring (CGM) solutions such as the Guardian Connect system.
Key features of the study:
This report provides an in-depth analysis of the China continuous glucose monitoring devices market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the China continuous glucose monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Medtronic Plc., Abbott Laboratories, Medtrum Technologies, Inc., Senseonics, Nemaura, STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc., Micron Technology Inc., Renesas Electronics Corporation, and Toshiba Corporation
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The China continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the China continuous glucose monitoring devices market
China Continuous Glucose Monitoring Devices Market, By Component:
China Continuous Glucose Monitoring Devices Market, By End User:
Hospitals & Clinics
Medtronic Plc. *
Medtrum Technologies, Inc.
Taiwan Semiconductor Manufacturing Company Limited
Microchip Technology Inc.
Texas Instruments Inc.
Micron Technology Inc.
Renesas Electronics Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook